Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 90 member A24 (FAM90A24, also annotated as FAM90A24P) is classified primarily as a pseudogene in the human genome (NCBI Gene ID: 441332; UniProt P0C7X0). It is part of a primate-specific gene family with similarity to other FAM90A genes, several of which are also pseudogenes. There is no evidence supporting its role as a functional protein, therapeutic target, or biomarker. Some pseudogenes have functions as regulatory RNAs, but there is no specific data linking FAM90A24 to such roles. No disease associations, interacting drugs, or mechanisms of action have been described for this locus. It is not considered a therapeutic target and typically not included in curated druggable genome or clinical databases.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 90 member A24 (FAM90A24).